Organoidsciences Ltd. (KOSDAQ:476040)
South Korea · Delayed Price · Currency is KRW 11,360
+230 (2.07%)
At close: Jun 9, 2026
Organoidsciences Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 2,295 | 2,407 | 1,953 | 1,591 | 438.24 | |
Revenue Growth (YoY) | 11.32% | 23.21% | 22.77% | 263.05% | - |
Cost of Revenue | 52.9 | 48.6 | 42.8 | 44.5 | 26.26 |
Gross Profit | 2,243 | 2,358 | 1,910 | 1,547 | 411.98 |
Selling, General & Admin | 11,388 | 11,526 | 8,563 | 6,211 | 4,560 |
Research & Development | 7,117 | 6,606 | 5,217 | 4,776 | 6,227 |
Amortization of Goodwill & Intangibles | 71.86 | 68.65 | 55.48 | 25.33 | 13.7 |
Other Operating Expenses | 36.74 | 35.51 | 32.11 | 44.04 | 38.26 |
Operating Expenses | 18,934 | 18,558 | 14,145 | 11,341 | 10,965 |
Operating Income | -16,692 | -16,200 | -12,235 | -9,795 | -10,553 |
Interest Expense | -343.36 | -363.32 | -3,190 | -5,992 | -4,906 |
Interest & Investment Income | 206.51 | 182.71 | 481.1 | 924.75 | 582.06 |
Currency Exchange Gain (Loss) | 22.37 | 22.37 | 19.35 | 18.98 | - |
Other Non Operating Income (Expenses) | 41.2 | 139.7 | 3,226 | -24,068 | -9,235 |
EBT Excluding Unusual Items | -16,765 | -16,219 | -11,699 | -38,911 | -24,111 |
Gain (Loss) on Sale of Investments | 357.5 | 479.76 | 163.05 | 43.05 | - |
Pretax Income | -16,408 | -15,739 | -11,536 | -38,868 | -24,111 |
Earnings From Continuing Operations | -16,408 | -15,739 | -11,536 | -38,868 | -24,111 |
Minority Interest in Earnings | 269.94 | 370.88 | 289.06 | 180.86 | - |
Net Income | -16,138 | -15,368 | -11,246 | -38,687 | -24,111 |
Net Income to Common | -16,138 | -15,368 | -11,246 | -38,687 | -24,111 |
Shares Outstanding (Basic) | - | 6 | 4 | 3 | 3 |
Shares Outstanding (Diluted) | - | 6 | 4 | 3 | 3 |
Shares Change (YoY) | - | 46.11% | 45.83% | - | - |
EPS (Basic) | - | -2516.68 | -2691.00 | -13499.65 | -8413.46 |
EPS (Diluted) | - | -2516.68 | -2691.00 | -13499.65 | -8413.46 |
Free Cash Flow | -18,453 | -15,912 | -9,808 | -8,196 | -10,304 |
Free Cash Flow Per Share | - | -2605.80 | -2346.73 | -2859.93 | -3595.68 |
Gross Margin | 97.69% | 97.98% | 97.81% | 97.20% | 94.01% |
Operating Margin | -727.15% | -673.16% | -626.38% | -615.62% | -2407.94% |
Profit Margin | -703.01% | -638.59% | -575.78% | -2431.56% | -5501.84% |
Free Cash Flow Margin | -803.86% | -661.20% | -502.11% | -515.13% | -2351.33% |
EBITDA | -15,212 | -14,755 | -10,931 | -8,651 | -9,748 |
D&A For EBITDA | 1,480 | 1,445 | 1,304 | 1,144 | 804.46 |
EBIT | -16,692 | -16,200 | -12,235 | -9,795 | -10,553 |
Advertising Expenses | - | 870.67 | 332.07 | 139.83 | 145.37 |